recombinant human tissue plasminogen activator ( rt-pa ) , produced by expression in chinese hamster ovary cells , is a fibrin-specific plasminogen activator which has been approved for clinical use in the treatment of myocardial infarction .
C0032143
recombinant
C0027051
myocardial infarction